Coronavirus | Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year

It will likely be at the very least a yr earlier than the corporate begins precise manufacturing.

After receiving permission to make Bharat Biotech’s COVID-19 vaccine Covaxin, Mumbai-based Haffkine Bio-Pharmaceutical on Friday stated it could take at the very least a yr for the corporate to start out precise manufacturing.A high official stated the state-run firm is concentrating on to supply 22.eight crore vials of the vaccine per yr.Chatting with reporters in Mumbai, Dr Sandeep Rathod, managing director, Haffkine Bio-Pharmaceutical Company Ltd, stated, “Our goal is to supply round 22.eight crore vaccine vials however it’s going to take one yr for us to start out manufacturing.” Hyderabad-based Bharat Biotech and the ICMR have developed Covaxin, one of many two vaccines getting used within the ongoing nationwide COVID-19 vaccination drive.
 “And now we acquired a contract to supply the vaccine at our Parel facility in Mumbai,” he stated.”A proposal was submitted in January this yr owing to the rising instances of coronavirus and want for extra vaccines to immunise a lot of folks. It’s an formidable undertaking which is essential from the angle of vaccination of such a big inhabitants,” stated the managing director of the Maharashtra authorities endeavor.“There will likely be an inner staff in addition to a technical staff to arrange the power for manufacturing of uncooked supplies. As soon as we obtain all of the clearances from the Centre about security and high quality requirements, we are going to begin vaccine manufacturing,” he stated.”The put in capability of the brand new facility will likely be of 22.eight crore vials per yr and we are going to make optimum use of it,” Dr Rathod stated.

Recent Articles

Related Stories

Leave A Reply

Please enter your comment!
Please enter your name here

Stay on op - Ge the daily news in your inbox